Related Experiment Video
Updated: Apr 15, 2026
07:17
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
Published on: May 9, 2018
8.6K
[Transurethral electroenucleation of benign prostatic hyperplasia]
Urologiia (Moscow, Russia : 1999)
|March 27, 2015
Summary
Transurethral monopolar electroenucleation effectively treats benign prostatic hyperplasia (BPH) by removing large tissue amounts with minimal bleeding. This urology technique offers a promising alternative for BPH management.
Area of Science:
- Urology
- Surgical Innovation
Background:
- Benign prostatic hyperplasia (BPH) treatment selection is a significant urological challenge.
- Infravesical obstruction due to large BPH necessitates effective surgical interventions.
Purpose of the Study:
- To evaluate the efficacy and safety of transurethral monopolar electroenucleation for large BPH.
- To compare this novel technique with traditional monopolar transurethral resection of the prostate (TURP).
Main Methods:
- Prospective study of 38 patients undergoing transurethral monopolar electroenucleation for large BPH.
- Control group of 44 patients treated with standard monopolar TURP.
- Comprehensive clinical and laboratory assessments preoperatively and at 1, 6, and 12 months post-surgery.
Main Results:
- The new technique demonstrated the ability to remove substantial adenomatous tissue.
- Low risk of bleeding complications was observed with monopolar electroenucleation.
- Early and late outcomes and complications were systematically evaluated.
Conclusions:
- Transurethral monopolar electroenucleation is a viable and advantageous method for treating large BPH.
- The technique offers effective tissue removal with a reduced risk of hemorrhagic complications compared to traditional TURP.
